Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
|
07.04.01 |
Drugs for urinary retention |
|
|
07.04.01 |
Parasympathomimetics |
|
|
07.04.01.02 |
5-Alpha reductase inhibitors |
|
|
Alfuzosin Hydrochloride (Besavar® XL)

|
Non Formulary
|
|
Alfuzosin Hydrochloride (Vasran® XL)

|
Non Formulary
|
|
Tamsulosin Hydrochloride (Flomaxtra® XL)

|
Non Formulary
|
|
Tamsulosin/Dutasteride (Combodart®)

|
Non Formulary
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
Status |
Description |

|
"Amber 1" - These are medicines that require significant monitoring and the decision to treat with an AMBER medicine should be made by specialists only |

|
"Amber 2" - These are medicines that require little or no monitoring by the GP, but should only be prescribed in general practice after they have been recommended following specialist referral. |

|
"Red" - Secondary care only |

|
"Double Red" - NOT recommended for prescribing in either primary or secondary care |

|
Traffic light status to be confirmed |

|
May be prescribed in primary and secondary care |
|
|